Protein metabolism in Turner syndrome and the impact of hormone replacement therapy

Clinical Endocrinology

Volumn 67, Issue 3, 2007, Pages 413-418

  Gravholt, Claus Højbjerg ^a   Riis, Anne Lene ^a   Møller, Niels ^a   Christiansen, Jens Sandahl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTODENE; MUSCLE PROTEIN; NITROGEN 15; NORETHISTERONE ACETATE; PHENYLALANINE; TRISEQUENS; TYROSINE;

ADULT; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; FOREARM; HORMONE SUBSTITUTION; HUMAN; KARYOTYPE; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RANDOMIZATION; TURNER SYNDROME;

ADULT; BODY COMPOSITION; CALORIMETRY, INDIRECT; CROSS-OVER STUDIES; DEUTERIUM; ENERGY METABOLISM; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MUSCLE, SKELETAL; NITROGEN ISOTOPES; PHENYLALANINE; PROGESTERONE; PROTEINS; TURNER SYNDROME; TYROSINE; YOUNG ADULT;

EID: 34548039227     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02902.x     Document Type: Article

References (39)

1. Park, E. (1977) Body shape in Turner's syndrome. Human Biology, 49, 215 223.
2. Varrela, J., Vinkka, H. Alvesalo, L. (1984) The phenotype of 45,X females: an anthropometric quantification. Annals of Human Biology, 11, 53 66.
3. Gravholt, C.H. Naeraa, R.W. (1997) Reference values for body proportions and body composition in adult women with Turner's syndrome. American Journal of Medical Genetics, 72, 403 408.
4. Gravholt, C.H., Naeraa, R.W., Brixen, K., Kastrup, K.W., Mosekilde, L., Jørgensen, J.O. Christiansen, J.S. (2002) Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity. A randomized double-blind, placebo-controlled cross-over study. Pediatrics, 110, 889 896.
5. Gravholt, C.H., Hjerrild, B.E., Naeraa, R.W., Engbaek, F., Mosekilde, L. Christiansen, J.S. (2005) Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Clinical Endocrinology, 62, 616 622.
6. Ostberg, J.E., Thomas, E.L., Hamilton, G., Attar, M.J., Bell, J.D. Conway, G.S. (2005) Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. Journal of Clinical Endocrinology and Metabolism, 90, 2631 2635.
7. Gravholt, C.H., Hjerrild, B.E., Mosekilde, L., Hansen, T.K., Rasmussen, L.M., Frystyk, J., Flyvbjerg, A. Christiansen, J.S. (2006) Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. European Journal of Endocrinology, 155, 583 592.
8. Gravholt, C.H., Juul, S., Naeraa, R.W. Hansen, J. (1998) Morbidity in Turner syndrome. Journal of Clinical Epidemiology, 51, 147 158.
9. Swerdlow, A.J., Hermon, C., Jacobs, P.A., Alberman, E., Beral, V., Daker, M., Fordyce, A. Youings, S. (2001) Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Annals of Human Genetics, 65, 177 188.
10. Stochholm, K., Juul, S., Juel, K., Naeraa, R.W. Gravholt, C.H. (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 91, 3897 3902.
11. Rosen, T. Bengtsson, B.A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285 288.
12. Bulow, B., Hagmar, L., Eskilsson, J. Erfurth, E.M. (2000) Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism, 85, 574 584.
13. Tomlinson, J.W., Holden, N., Hills, R.K., Wheatley, K., Clayton, R.N., Bates, A.S., Sheppard, M.C. Stewart, P.M. (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet, 357, 425 431.
14. van der Schouw, Y.T.G.Y., Steyerberg, E.W., Eijkemans, J.C. Banga, J.D. (1996) Age at menopause as a risk factor for cardiovascular mortality. Lancet, 347, 714 718.
15. Mauras, N. (1995) Estrogens do not affect whole-body protein metabolism in the prepubertal female. Journal of Clinical Endocrinology and Metabolism, 80, 2842 2845.
16. Toth, M.J., Poehlman, E.T., Matthews, D.E., Tchernof, A. MacCoss, M.J. (2001) Effects of estradiol and progesterone on body composition, protein synthesis, and lipoprotein lipase in rats. American Journal of Physiology. Endocrinology and Metabolism, 280, E496 E501.
17. Rutherford, O.M. Jones, D.A. (1992) The relationship of muscle and bone loss and activity levels with age in women. Age and Ageing, 21, 286 293.
18. Phillips, S.K., Rook, K.M., Siddle, N.C., Bruce, S.A. Woledge, R.C. (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clinical Science (London), 84, 95 98.
19. Jensen, J., Christiansen, C. Rodbro, P. (1986) Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women. Maturitas, 8, 209 216.
20. Sorensen, M.B., Rosenfalck, A.M., Hojgaard, L. Ottesen, B. (2001) Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obesity Research, 9, 622 626.
21. Gravholt, C.H., Naeraa, R.W., Fisker, S. Christiansen, J.S. (1997) Body composition and physical fitness are major determinants of the growth hormone-IGF axis aberrations in adult Turner syndrome, with important modulations by treatment with 17-beta-estradiol. Journal of Clinical Endocrinology and Metabolism, 82, 2570 2577.
22. Gravholt, C.H., Hansen, K.W., Erlandsen, M., Ebbehoj, E. Christiansen, J.S. (2006) Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. Journal of Hypertension, 24, 353 360.
23. Heitmann, B.L. (1994) Impedance: a valid method in assessment of body composition? European Journal of Clinical Nutrition, 48, 228 240.
24. Moller, N., Butler, P.C., Antsiferov, M.A. Alberti, K.G. (1989) Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia, 32, 105 110.
25. 5]phenylalanine model. American Journal of Physiology, 256, E631 E639.
26. Nair, K.S., Ford, G.C., Ekberg, K., Fernqvist Forbes, E. Wahren, J. (1995) Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. Journal of Clinical Investigation, 95, 2926 2937.
27. Copeland, K.C. Nair, K.S. (1994) Acute growth hormone effects on amino acid and lipid metabolism. Journal of Clinical Endocrinology and Metabolism, 78, 1040 1047.
28. Orskov, H., Thomsen, H.G. Yde, H. (1968) Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature, 219, 193 195.
29. Gravholt, C.H., Naeraa, R.W., Andersson, A.M., Christiansen, J.S. Skakkebaek, N.E. (2002) Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty. Human Reproduction, 17, 2049 2053.
30. Mauras, N., Vieira, N.E. Yergey, A.L. (1997) Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study. Metabolism, 46, 908 913.
31. Rebuffe Scrive, M., Lonnroth, P., Marin, P., Wesslau, C., Bjorntorp, P. Smith, U. (1987) Regional adipose tissue metabolism in men and postmenopausal women. International Journal of Obesity, 11, 347 355.
32. Haarbo, J., Marslew, U., Gotfredsen, A. Christiansen, C. (1991) Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism, 40, 1323 1326.
33. Rebuffe Scrive, M., Eldh, J., Hafstrom, L.O. Bjorntorp, P. (1986) Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause. Metabolism, 35, 792 797.
34. Jensen, M.D., Martin, M.L., Cryer, P.E. Roust, L.R. (1994) Effects of estrogen on free fatty acid metabolism in humans. American Journal of Physiology, 266, E914 E920.
35. Pedersen, S.B., Kristensen, K., Hermann, P.A., Katzenellenbogen, J.A. Richelsen, B. (2004) Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. Journal of Clinical Endocrinology and Metabolism, 89, 1869 1878.
36. Snajderova, M., Mardesic, T., Lebl, J., Gerzova, H., Teslik, L. Zapletalova, J. (2003) The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Hormone Research, 60, 198 204.
37. Ostberg, J.E., Storry, C., Donald, A.E., Attar, M.J., Halcox, J.P. Conway, G.S. (2007) A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clinical Endocrinology, 66, 557 564.
38. Gravholt, C.H., Svenstrup, B., Bennett, P. Christiansen, J.S. (1999) Low androgen levels in adult Turner syndrome: influence of female sex hormones and growth hormone status. Clinical Endocrinology, 50, 791 800.
39. Godsland, I.F. (2005) Oestrogens and insulin secretion. Diabetologia, 48, 2213 2220.